Daniel Raynor - Net Worth and Insider Trading

Daniel Raynor Net Worth

The estimated net worth of Daniel Raynor is at least $23 Million dollars as of 2026-08-08. Daniel Raynor is the Director of ANI Pharmaceuticals Inc and owns about 289,003 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $23 Million. Details can be seen in Daniel Raynor's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Raynor has not made any transactions after 2018-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Daniel Raynor

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Daniel Raynor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Raynor owns 2 companies in total, including ANI Pharmaceuticals Inc (ANIP) , and EQM Technologies & Energy Inc (EQTE) .

Click here to see the complete history of Daniel Raynor’s form 4 insider trades.

Insider Ownership Summary of Daniel Raynor

Ticker Company Transaction Date Type of Owner
ANIP ANI Pharmaceuticals Inc 2018-03-19 director
EQTE EQM Technologies & Energy Inc 2013-11-12 10 percent owner

Daniel Raynor Latest Holdings Summary

Daniel Raynor currently owns a total of 1 stock. Daniel Raynor owns 289,003 shares of ANI Pharmaceuticals Inc (ANIP) as of March 19, 2018, with a value of $23 Million.

Latest Holdings of Daniel Raynor

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANIP ANI Pharmaceuticals Inc 2018-03-19 289,003 78.45 22,672,285

Holding Weightings of Daniel Raynor


Daniel Raynor Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Raynor has made a total of 0 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 7,215 shares on March 19, 2018, which brought Daniel Raynor around $439,033.

Insider Trading History of Daniel Raynor

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Raynor Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Daniel Raynor owns.
View ANIP Analysis

Daniel Raynor Ownership Network

Ownership Network List of Daniel Raynor

No Data

Ownership Network Relation of Daniel Raynor

Insider Network Chart


Daniel Raynor Owned Company Details

What does ANI Pharmaceuticals Inc do?

Who are the key executives at ANI Pharmaceuticals Inc?

Daniel Raynor is the director of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include Vice President and CFO Stephen P. Carey , SR. VP & GENERAL COUNSEL & SEC. Meredith Cook , and SVP & HEAD - ESTABLISHED BRANDS Thomas Andrew Rowland .

ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary

Over the past 18 months, Daniel Raynor made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 7,900 shares made by Meredith Cook , a net sale of 18,637 shares made by Krista Davis , and a net sale of 69,637 shares made by Stephen P. Carey .

In summary, during the past 3 months, insiders sold 88,029 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 88,029 shares. During the past 18 months, 600,878 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 600,878 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ANI Pharmaceuticals Inc Insider Transactions

No Available Data

Daniel Raynor Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Raynor. Currently GuruFocus does not have mailing address information for Daniel Raynor.